| 000 | 01847 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517014014.0 | ||
| 264 | 0 | _c20161101 | |
| 008 | 201611s 0 0 spa d | ||
| 022 | _a0210-5705 | ||
| 024 | 7 |
_a10.1016/j.gastrohep.2014.12.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartín Mateos, Rosa M | |
| 245 | 0 | 0 |
_a[Is it possible to stop treatment with nucleos(t)ide analogs in patients with e-antigen negative chronic hepatitis B? Experience and new expectations]. _h[electronic resource] |
| 260 |
_bGastroenterologia y hepatologia _cMay 2015 |
||
| 300 |
_a305-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlanine Transaminase _xblood |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAspartate Aminotransferases _xblood |
| 650 | 0 | 4 |
_aDNA, Viral _xisolation & purification |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis B e Antigens _ximmunology |
| 650 | 0 | 4 |
_aHepatitis B virus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNucleotides _xtherapeutic use |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMoreira Vicente, Víctor F | |
| 700 | 1 | _aTavío Hernández, Eduardo | |
| 700 | 1 | _aCuño Roldán, Jose Luis | |
| 700 | 1 | _aTéllez Villajos, Luis | |
| 700 | 1 | _aAicart Ramos, Marta | |
| 700 | 1 | _aArribas Anta, Julia | |
| 700 | 1 | _aZaera de la Fuente, Celia | |
| 700 | 1 | _aAlbillos Martínez, Agustín | |
| 773 | 0 |
_tGastroenterologia y hepatologia _gvol. 38 _gno. 5 _gp. 305-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.gastrohep.2014.12.001 _zAvailable from publisher's website |
| 999 |
_c24579805 _d24579805 |
||